Could a 10-Minute breathing trick help dialysis patients sleep better?
NCT ID NCT07700693
First seen Jul 14, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study investigates whether a simple breathing exercise called the 4-7-8 technique can reduce fatigue and improve sleep in people undergoing hemodialysis for chronic kidney disease. Eighty adult patients are randomly assigned to either practice the breathing exercise twice daily for four weeks or continue with usual care. Fatigue levels, sleep quality, and daytime sleepiness are measured before, during, and after the program using standard questionnaires. The goal is to see if this safe, low-cost, non-drug approach can help manage two common and burdensome symptoms in dialysis patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a behavioral intervention using the 4-7-8 breathing technique
- What this could lead to
- If effective, this breathing exercise could offer a safe, drug-free way to help dialysis patients manage fatigue and sleep problems at home.
- What could go wrong
- This is a small, early-stage trial with 80 participants, so results may not apply to all dialysis patients. The benefit may be modest or no different from usual care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 85 years * Receiving hemodialysis treatment for at least 3 months * No diagnosis of malignant respiratory disease (e.g., bronchial or lung cancer) * No pathological condition affecting consciousness or focus (e.g., dialysis dementia or uremic encephalopathy) * Native Turkish speaker Exclusion Criteria: * Advanced reading comprehension problems * Advanced hearing impairment * Presence of sleep apnea * Known psychiatric illness.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 4-7-8 breathing technique are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a sleep drug help cirrhosis patients rest and think clearer?
- Can a food and friendship program slow kidney disease?
- Can magnetic brain zaps ease the pain of a sleepless body?
- Can poor sleep make you hurt more? study probes Insomnia's link to pain
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin